GLP-1s
Article
Keeping member health on track: A snapshot of the PBM’s clinical expertise
Express Scripts is helping patients understand and manage their conditions through comprehensive disease management.
Read More
Article
Enhancing health outcomes and savings through value-based solutions
Patient engagement paired with cost-containment strategies drives better health outcomes and reduces the financial burden for plan sponsors.
Read More
Article
What’s on the horizon for nonalcoholic steatohepatitis (NASH) treatment?
The future of NASH treatment is more promising than ever with improved methods for diagnosis and new drugs in development.
Read More
Article
GLP-1s and digital support: A winning combination
When GLP-1s aren’t enough, lifestyle modification can be key to weight management.
Read More
Article
Easing the impact of GLP-1s
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
Read MoreArticle
A plan sponsor’s guide to GLP-1 medications for weight loss
July 10, 2023
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...